Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2026

Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-04-17

Pages: 118 Pages

Report ld: 6469436

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Infectious Diseases Molecular Diagnostics Kit Market Size(US$)

CAGR 2026-2032

7.5%

Market Size,2032

USD 35,060

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 22,720 million

Market Forecast in 2032(Value)

US$ 35,060 million

CAGR

7.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Infectious Diseases Molecular Diagnostics Kit market was valued at US$ 21280 million in 2025 and is anticipated to reach US$ 35060 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Infectious Diseases Molecular Diagnostics Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics Kit. The Infectious Diseases Molecular Diagnostics Kit market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Infectious Diseases Molecular Diagnostics Kit market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Infectious Diseases Molecular Diagnostics Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others

Segment by Application

Hospital
Third-party Testing Agency
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Infectious Diseases Molecular Diagnostics Kit companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Polymerase Chain Reaction PCR

1.2.3 Molecular Hybridization

1.2.4 Biochip

1.2.5 Others

1.3 Market by Application

1.3.1 Global Infectious Diseases Molecular Diagnostics Kit Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Third-party Testing Agency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Perspective (2021–2032)

2.2 Global Infectious Diseases Molecular Diagnostics Kit Growth Trends by Region

2.2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Region (2021–2026)

2.2.3 Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Region (2027–2032)

2.3 Infectious Diseases Molecular Diagnostics Kit Market Dynamics

2.3.1 Infectious Diseases Molecular Diagnostics Kit Industry Trends

2.3.2 Infectious Diseases Molecular Diagnostics Kit Market Drivers

2.3.3 Infectious Diseases Molecular Diagnostics Kit Market Challenges

2.3.4 Infectious Diseases Molecular Diagnostics Kit Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infectious Diseases Molecular Diagnostics Kit Players by Revenue

3.1.1 Global Top Infectious Diseases Molecular Diagnostics Kit Players by Revenue (2021–2026)

3.1.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Players (2021–2026)

3.2 Global Top Infectious Diseases Molecular Diagnostics Kit Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Infectious Diseases Molecular Diagnostics Kit Revenue

3.4 Global Infectious Diseases Molecular Diagnostics Kit Market Concentration Ratio

3.4.1 Global Infectious Diseases Molecular Diagnostics Kit Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Kit Revenue in 2025

3.5 Global Key Players of Infectious Diseases Molecular Diagnostics Kit Head Offices and Areas Served

3.6 Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Products and Applications

3.7 Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Infectious Diseases Molecular Diagnostics Kit Breakdown Data by Type

4.1 Global Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Type (2021–2026)

4.2 Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Type (2027–2032)

5 Infectious Diseases Molecular Diagnostics Kit Breakdown Data by Application

5.1 Global Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Application (2021–2026)

5.2 Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Infectious Diseases Molecular Diagnostics Kit Market Size (2021–2032)

6.2 North America Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2021–2026)

6.4 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infectious Diseases Molecular Diagnostics Kit Market Size (2021–2032)

7.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2021–2026)

7.4 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size (2021–2032)

8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2021–2026)

8.4 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Infectious Diseases Molecular Diagnostics Kit Market Size (2021–2032)

9.2 Latin America Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2021–2026)

9.4 Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size (2021–2032)

10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2021–2026)

10.4 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Introduction

11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Qiagen

11.2.1 Qiagen Company Details

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Introduction

11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.2.5 Qiagen Recent Development

11.3 Illumina

11.3.1 Illumina Company Details

11.3.2 Illumina Business Overview

11.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Introduction

11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.3.5 Illumina Recent Development

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Introduction

11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.4.5 Abbott Recent Development

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Introduction

11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.5.5 Hologic Recent Development

11.6 BioMerieux

11.6.1 BioMerieux Company Details

11.6.2 BioMerieux Business Overview

11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Introduction

11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.6.5 BioMerieux Recent Development

11.7 Danaher (Cepheid)

11.7.1 Danaher (Cepheid) Company Details

11.7.2 Danaher (Cepheid) Business Overview

11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Introduction

11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.7.5 Danaher (Cepheid) Recent Development

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Details

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Introduction

11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.8.5 Myriad Genetics Recent Development

11.9 DAAN Gene

11.9.1 DAAN Gene Company Details

11.9.2 DAAN Gene Business Overview

11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Introduction

11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.9.5 DAAN Gene Recent Development

11.10 Agilent

11.10.1 Agilent Company Details

11.10.2 Agilent Business Overview

11.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Introduction

11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.10.5 Agilent Recent Development

11.11 Genomic Health

11.11.1 Genomic Health Company Details

11.11.2 Genomic Health Business Overview

11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Introduction

11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.11.5 Genomic Health Recent Development

11.12 BD

11.12.1 BD Company Details

11.12.2 BD Business Overview

11.12.3 BD Infectious Diseases Molecular Diagnostics Kit Introduction

11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.12.5 BD Recent Development

11.13 Foundation Medicine

11.13.1 Foundation Medicine Company Details

11.13.2 Foundation Medicine Business Overview

11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Introduction

11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

11.13.5 Foundation Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Polymerase Chain Reaction PCR

Table 3. Key Players of Molecular Hybridization

Table 4. Key Players of Biochip

Table 5. Key Players of Others

Table 6. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region (US$ Million), 2021–2026

Table 9. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2021–2026)

Table 10. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2027–2032)

Table 12. Infectious Diseases Molecular Diagnostics Kit Market Trends

Table 13. Infectious Diseases Molecular Diagnostics Kit Market Drivers

Table 14. Infectious Diseases Molecular Diagnostics Kit Market Challenges

Table 15. Infectious Diseases Molecular Diagnostics Kit Market Restraints

Table 16. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (US$ Million), 2021–2026

Table 17. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Players (2021–2026)

Table 18. Global Top Infectious Diseases Molecular Diagnostics Kit Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infectious Diseases Molecular Diagnostics Kit Revenue, 2025

Table 19. Ranking of Global Top Infectious Diseases Molecular Diagnostics Kit Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Headquarters and Area Served

Table 22. Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Products and Applications

Table 23. Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (US$ Million), 2021–2026

Table 26. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Type (2021–2026)

Table 27. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Type (2027–2032)

Table 29. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application (US$ Million), 2021–2026

Table 30. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Application (2021–2026)

Table 31. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Application (2027–2032)

Table 33. North America Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2021–2026

Table 35. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (US$ Million), 2027–2032

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Infectious Diseases Molecular Diagnostics Kit Product

Table 51. Roche Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 52. Roche Recent Development

Table 53. Qiagen Company Details

Table 54. Qiagen Business Overview

Table 55. Qiagen Infectious Diseases Molecular Diagnostics Kit Product

Table 56. Qiagen Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 57. Qiagen Recent Development

Table 58. Illumina Company Details

Table 59. Illumina Business Overview

Table 60. Illumina Infectious Diseases Molecular Diagnostics Kit Product

Table 61. Illumina Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 62. Illumina Recent Development

Table 63. Abbott Company Details

Table 64. Abbott Business Overview

Table 65. Abbott Infectious Diseases Molecular Diagnostics Kit Product

Table 66. Abbott Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 67. Abbott Recent Development

Table 68. Hologic Company Details

Table 69. Hologic Business Overview

Table 70. Hologic Infectious Diseases Molecular Diagnostics Kit Product

Table 71. Hologic Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 72. Hologic Recent Development

Table 73. BioMerieux Company Details

Table 74. BioMerieux Business Overview

Table 75. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product

Table 76. BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 77. BioMerieux Recent Development

Table 78. Danaher (Cepheid) Company Details

Table 79. Danaher (Cepheid) Business Overview

Table 80. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product

Table 81. Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 82. Danaher (Cepheid) Recent Development

Table 83. Myriad Genetics Company Details

Table 84. Myriad Genetics Business Overview

Table 85. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product

Table 86. Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 87. Myriad Genetics Recent Development

Table 88. DAAN Gene Company Details

Table 89. DAAN Gene Business Overview

Table 90. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product

Table 91. DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 92. DAAN Gene Recent Development

Table 93. Agilent Company Details

Table 94. Agilent Business Overview

Table 95. Agilent Infectious Diseases Molecular Diagnostics Kit Product

Table 96. Agilent Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 97. Agilent Recent Development

Table 98. Genomic Health Company Details

Table 99. Genomic Health Business Overview

Table 100. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product

Table 101. Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 102. Genomic Health Recent Development

Table 103. BD Company Details

Table 104. BD Business Overview

Table 105. BD Infectious Diseases Molecular Diagnostics Kit Product

Table 106. BD Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 107. BD Recent Development

Table 108. Foundation Medicine Company Details

Table 109. Foundation Medicine Business Overview

Table 110. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product

Table 111. Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Kit Business (US$ Million), 2021–2026

Table 112. Foundation Medicine Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Infectious Diseases Molecular Diagnostics Kit Picture

Figure 2. Global Infectious Diseases Molecular Diagnostics Kit Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Type: 2025 vs 2032

Figure 4. Polymerase Chain Reaction PCR Features

Figure 5. Molecular Hybridization Features

Figure 6. Biochip Features

Figure 7. Others Features

Figure 8. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application: 2025 vs 2032

Figure 10. Hospital Case Studies

Figure 11. Third-party Testing Agency Case Studies

Figure 12. Others Case Studies

Figure 13. Infectious Diseases Molecular Diagnostics Kit Report Years Considered

Figure 14. Global Infectious Diseases Molecular Diagnostics Kit Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Infectious Diseases Molecular Diagnostics Kit Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region: 2025 vs 2032

Figure 17. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Players in 2025

Figure 18. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue in 2025

Figure 20. North America Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2021–2032)

Figure 22. United States Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2021–2032)

Figure 26. Germany Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2021–2032)

Figure 34. China Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2021–2032)

Figure 42. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2021–2032)

Figure 46. Israel Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Roche Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 50. Qiagen Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 51. Illumina Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 52. Abbott Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 53. Hologic Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 54. BioMerieux Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 55. Danaher (Cepheid) Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 56. Myriad Genetics Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 57. DAAN Gene Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 58. Agilent Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 59. Genomic Health Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 60. BD Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 61. Foundation Medicine Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Infectious Diseases Molecular Diagnostics Kit market? zhanKai

The top companies in the global Infectious Diseases Molecular Diagnostics Kit market are Roche、Qiagen、Illumina.

What was the global market size of Infectious Diseases Molecular Diagnostics Kit in 2026? shouQi

What is the annual compound growth rate of the global Infectious Diseases Molecular Diagnostics Kit market size from 2026 to 2032? shouQi

What was the global market size of Infectious Diseases Molecular Diagnostics Kit in 2032? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 21280 million in 2025 and is projected to reach US$ 35060 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 115
USD 3950.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 19930 million in 2024 to US$ 32840 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 142
USD 4900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
The global market for Infectious Diseases Molecular Diagnostics Kit was valued at US$ 19930 million in the year 2024 and is projected to reach a revised size of US$ 32840 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Infectious Diseases Molecular Diagnostics Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 19930 million in 2024 and is forecast to a readjusted size of US$ 32840 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 108
USD 3950.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Insights, Forecast to 2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-04-12
Pages: 110
USD 4900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-01-12
Pages: 86
USD 2900.00
(Single User License)
Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-01-08
Pages: 108
USD 3950.00
(Single User License)

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 21280 million in 2025 and is projected to reach US$ 35060 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 115
USD 3950.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 19930 million in 2024 to US$ 32840 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 142
USD 4900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
The global market for Infectious Diseases Molecular Diagnostics Kit was valued at US$ 19930 million in the year 2024 and is projected to reach a revised size of US$ 32840 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-16
Pages: 82
USD 2900.00 (Single User License)
Infectious Diseases Molecular Diagnostics Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 19930 million in 2024 and is forecast to a readjusted size of US$ 32840 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 108
USD 3950.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Insights, Forecast to 2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-04-12
Pages: 110
USD 4900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-01-12
Pages: 86
USD 2900.00 (Single User License)
Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-01-08
Pages: 108
USD 3950.00 (Single User License)